No. EBOO is not FDA-approved as a treatment for any specific condition. Medical ozone has a long history of clinical use in Europe and is studied in peer-reviewed literature, but it falls outside standard FDA approval pathways as a therapy. At SynergyO3, EBOO is offered as adjunctive support — meaning it works alongside, not in place of, evidence-based medical care. Dr. Volpp is transparent about this distinction with every patient.
Yes, and we take this seriously. G6PD deficiency is an absolute contraindication — ozone therapy in a G6PD-deficient patient can cause hemolytic anemia. Active bleeding disorders, uncontrolled hyperthyroidism, pregnancy, and recent cardiac events are also considerations. Dr. Volpp screens for these in your consultation. If you have a contraindication, she will tell you clearly and recommend appropriate alternatives.
During the session, most patients describe it as quiet and unremarkable — you sit in a reclining chair for approximately 60 minutes while the EBOO circuit runs. There is minimal discomfort beyond the IV placement. Afterward, some patients feel slightly fatigued, while others report feeling clearer within 24–48 hours. Individual responses vary considerably.
This depends entirely on your condition, baseline health, and goals — which is why we require a consultation before booking sessions. Some patients see meaningful improvement after three to five sessions; others benefit from ongoing periodic treatment. Dr. Volpp reassesses your protocol at each visit.
In most cases, yes. SynergyO3 is explicitly designed to work alongside your existing medical care — not to replace it. Dr. Volpp will ask about all current medications and treatments during your consultation and will flag any potential interactions.
EBOO processes a significantly larger blood volume per session than single-pass ozone IV therapy (MAH). The blood passes through a filter and a closed ozone circuit. HOCATT delivers ozone transdermally through steam — a different mechanism and a different use case. Dr. Volpp can help you determine which approach is appropriate for your specific situation.
EBOO therapy is generally not covered by standard health insurance plans. SynergyO3 operates on a direct-pay model. In some cases, HSA and FSA funds may be applicable — we can provide a detailed superbill.
A 1:1 appointment with Dr. Volpp to review your health history, answer every question you have, and determine whether EBOO — or any other approach at SynergyO3 — is appropriate for you. No obligation. Complete transparency.
Consultation fee of $150 is credited toward your first EBOO session if you proceed. Individual results vary. EBOO is not FDA-approved to treat any disease.